Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan

Fujita Health University Hospital, Aichi

Chiba University Hospital, Chiba

Hiroshima University Hospital, Hiroshima

Kawasaki Municipal Hospital, Kanagawa

Tokai University Hospital, Kanagawa

Tohoku University Hospital, Miyagi

Nagoya University Hospital, Nagoya

Seirei Hamamatsu General Hospital, Shizuoka

Keio University Hospital, Tokyo

National Hospital Organization Tokyo Medical Center, Tokyo

Nippon Medical School Hospital, Tokyo

Toho University Ohashi Medical Center, Tokyo

Chungbuk National University Hospital, Cheongju-si

Chungnam National University Hospital, Daejeon

Gachon University Gil Medical Center, Incheon

Seoul National University Bundang Hospital, Seongnam

Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

Chang Gung Medical Foundation, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

China Medical University Hospital, Taichung

National Cheng Kung University Hospital, Tainan City

National Taiwan University Hospital, Taipei

Chang Gung Medical Foundation, Linkou Chang Gung Memorial Hospital, Taoyuan District